Importantly, overexpression of ALAS2 significantly ameliorated these phenomena, suggesting that ALAS2 could be used as a ferroptosis inhibitor to minimize the degree of intestinal damage in NEC. This evidence concerns the gene ALAS2 and necrotizing enterocolitis.